Wnt pathway antagonists and angiogenesis.
10.1007/s13238-010-0112-0
- Author:
Bin ZHANG
1
;
Jian-Xing MA
Author Information
1. Department of Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
- Publication Type:Journal Article
- MeSH:
Adaptor Proteins, Signal Transducing;
metabolism;
Animals;
Humans;
Neovascularization, Pathologic;
physiopathology;
Repressor Proteins;
metabolism;
Signal Transduction;
physiology;
Wnt Proteins;
antagonists & inhibitors
- From:
Protein & Cell
2010;1(10):898-906
- CountryChina
- Language:English
-
Abstract:
Dysregulation of the Wnt pathway has been extensively studied in multiple diseases, including some angiogenic disorders. Wnt signaling activation is a major stimulator in pathological angiogenesis and thus, Wnt antagonists are believed to have therapeutic potential for neovascular disorders. Actually, some Wnt antagonists have been identified directly from the anti-angiogenic factor family. This review summarizes the recent progress toward understanding of the roles of Wnt pathway antagonists in angiogenic regulation and their mechanism of action, and exploring their therapeutic potential.
